Renaissance Technologies
ICCM icon

Renaissance Technologies’s IceCure Medical ICCM Stock Holding History

Renaissance Technologies’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-363
Closed -$12K – 3621
2024
Q4 		$12K Buy
+363
New +$8.31K ﹤0.01% 3511
2024
Q3 		– Sell
-2,213
Closed -$49.1K – 3686
2024
Q2 		$49.1K Buy
+2,213
New +$70.5K ﹤0.01% 3294
2024
Q1 		– Sell
-550
Closed -$18K – 3865
2023
Q4 		$18K Buy
+550
New +$14.6K ﹤0.01% 3588
2023
Q3 		– Sell
-630
Closed -$22K – 3860
2023
Q2 		$22K Buy
+630
New +$22.6K ﹤0.01% 3759

Other funds holding ICCM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies's ICCM Position: Q1 2025 in Review

Renaissance Technologies sold out of IceCure Medical (ICCM) in Q1 2025, closing a stake of 363 shares — an estimated $12K sold.

Renaissance Technologies first reported a position in ICCM in Q2 2023 and held it in 4 quarters. The position peaked at $49.1K in Q2 2024. 13 funds tracked by Wall St. Rank hold ICCM as of Q1 2025.

  • Renaissance Technologies reported no remaining IceCure Medical position as of Q1 2025 after selling out during the quarter.
  • Renaissance Technologies sold 363 IceCure Medical shares in Q1 2025, an estimated $12K.
  • Renaissance Technologies first reported a position in IceCure Medical in Q2 2023 and held it in 4 quarters.
  • Renaissance Technologies's IceCure Medical position peaked at $49.1K in Q2 2024.
  • 13 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.